Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani

Leena Keurulainen, Antti Siiskonen, Abedelmajeed Nasereddin, Dmitry Kopelyanskiy, Nina Sacerdoti-Sierra, Teppo O. Leino, Paivi Tammela, Jari Yli-Kauhaluoma, Charles L. Jaffe, Paula Kiuru

Research output: Contribution to journalArticleScientificpeer-review

17 Citations (Scopus)

Abstract

A set of 56 2-arylbenzimidazoles was designed, synthesized and tested against Leishmania donovani amastigotes. The left- and right-hand side rings of the molecule, as well as the amide linker were modified. Structurally different derivatives were screened on Leishmania donovani axenic amastigotes at concentrations of 5, 15 and 50 mu M, and the ten most active derivatives were selected for further testing. 2-Arylbenzimidazole derivative 24 was active against Leishmania donovani-infected THP-1 cells showing 46% parasite inhibition at 5 mu M. (C) 2015 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)1933-1937
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume25
Issue number9
DOIs
Publication statusPublished - 1 May 2015
Externally publishedYes
Publication typeA1 Journal article-refereed

Funding

This study was supported by the Academy of Finland (projects 264020 and 265481 to J.Y.K.), and the Michael and Penny Feiwel Professorial Chair of Dermatology (C.L.J.).

Keywords

  • 2-Arylbenzimidazoles
  • Leishmania donovani
  • Antileishmanial activity
  • Biological activity
  • Medicinal chemistry
  • CHLAMYDIA-PNEUMONIAE
  • AMASTIGOTES
  • DERIVATIVES
  • INHIBITORS
  • ANALOGS
  • DESIGN

Fingerprint

Dive into the research topics of 'Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani'. Together they form a unique fingerprint.

Cite this